Circanol en es it fr

Circanol Brand names, Circanol Analogs

Circanol Brand Names Mixture

  • No information avaliable

Circanol Chemical_Formula


Circanol RX_link

No information avaliable

Circanol fda sheet

Circanol msds (material safety sheet)

Circanol Synthesis Reference

No information avaliable

Circanol Molecular Weight

591.741 g/mol

Circanol Melting Point

No information avaliable

Circanol H2O Solubility

No information avaliable

Circanol State


Circanol LogP


Circanol Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Circanol Indication

For use as an adjunct therapy for patients with dementia

Circanol Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Circanol Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Circanol side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Circanol Patient Information

No information avaliable

Circanol Organisms Affected

Humans and other mammals